{"acquisitions":[],"changes":[],"country":"US","description":"Akanocure develops novel small-molecule drugs targeting orphan and unmet oncology indications. It serves clinicians and patients facing metastatic cancers (90% of cancer deaths). Differentiator: combines chemistry-methodology expertise with classic drug-discovery practices.","domain":"akanocure.com","employees":null,"founded":2020,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":[],"lat":40.466571,"lng":-86.932703,"location":"West Lafayette, USA","multiples":[],"name":"Akanocure Pharmaceuticals INC","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":1000000,"connectionsAmong":[],"currency":"USD","date":"2024-01-01","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"akanocure-com-2024-01-01-strategic","source":{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-02","status":"attributed","url":null},"status":"attributed","type":"strategic","url":null}],"slug":"akanocure-com","sources":[{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-02","status":"attributed","url":null},{"fact":"existence","publisher":"akanocure.com","retrievedAt":"2026-05-02","status":"self-reported","url":"https://akanocure.com"},{"fact":"description","publisher":"akanocure.com","retrievedAt":"2026-05-02","status":"self-reported","url":"https://akanocure.com"}],"stage":"series-b+","stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":["GoDaddy Website Builder 7.0.5350"],"totalRaisedUsd":1000000,"traction":[],"updatedAt":"2026-05-02","valuations":[]}